Onychomycosis: Why Test?
Onychomycosis can cause pain, discomfort, and disfigurement; affecting quality of life. Using PCR, Ipsum Diagnostics will rapidly identify the disease-causing agent with a high rate of specificity and reproducibility. Fast, reliable results assist the physician to develop an effective treatment plan.
Once you know the RIGHT BUG you can select the RIGHT DRUG.
Easy Collection Process
Procuring samples for onychomycosis testing is easy. There are no special surgical procedures or storage requirements. Collection swabs and containers can be stored at room temperature. To ship, simply call Pain Rehab Products or lpsum Diagnostics to schedule a pickup. Pain Rehab Products and lpsum Diagnostics will train you and your staff on collection technique and provide all supplies for specimen collection and shipping.
What Is PCR
PCR , short for polymerase chain reaction, is a lab technique that takes small quantities of DNA and amplifies or increases their number. UtilizingTaqMan probes, DNA is amplified using a targeted approach to identify pathogens down to the species level. Impsum Diagnostics’ PCR techniques are highly sensitive, specific, and reproducible, allowing for rapid analysis of biological samples.
Additional Histology Testing:
PAS (Periodic Acid-Schiff), GMS (Gomori’s Methenamine Silver), FM (Fontana Mason) stains
lpsum Diagnostics is a leader in Directed Personalized Onchomycosis Molecular Medicine.
Qualitative AND Quantitative Results: Comprehensive testing identifies both bacteria and fungi species in relative quantities with antibiotic resistance markers if present. Accurate results help determine the right plan and avoid costly and ineffective treatments.
Rapid Turn-around Time Results provided as quickly as the same day sample received, in a straightforward and informative report including evidence-based treatment options, available immediately to physicians by online portal or fax. Get the answers you need to inform best practice in a timely manner.
Ipsum Diagnostics’ Experienced Technical Team accredited with CLIA High-Complexity Laboratory standards include Director Henry Skelton, MD board certified in anatomical and clinical pathology and dermatopathology; Maggie Hopkins, MD MBA FASCP, board certified in clinical pathology and experienced in molecular pathology and microbiology; and Lucy Feingold Ph.D., board certified in molecular biology. With a combined 70-plus years’ experience, our team has the know-how to ensure the highest quality of testing.